Insights On CONTRACT PHARMA MANUFACTURING

  1. Bora Pharmaceuticals: A Future Focused CDMO 3/25/2025

    Specializing in formulation development, clinical and commercial manufacturing, and advanced packaging solutions, we bring expertise across a diverse range of dosage forms.

  2. Who's In Charge? How To Ensure Effective Trial Oversight, Leadership 3/19/2025

    Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.

  3. One-Step SAR: Using High-Content Imaging To Drive Small Molecule Protein Degraders From Hit To Lead 3/18/2025

    Discover Curia’s cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system to efficiently identify small molecule protein degraders with rich, multi-dimensional data.

  4. Digging Into Manufacturing Priorities For Viral Vectors 3/18/2025

    Addressing the complexities of viral vector manufacturing through strategic internalization, advanced technologies, and regulatory excellence is crucial for the future of gene therapies.

  5. Developing Scalable, Global Solutions For Cell & Gene Manufacturing 3/18/2025

    Cell and gene therapies offer transformative potential for treating complex diseases, but their manufacturing and global delivery face significant challenges.

  6. Streamline The Path To FIH Trials With Advanced Cell Line Development 3/18/2025

    Many CDMOs cannot handle complex recombinant proteins, which often require a CLD process fully integrated with other CDMO components, including analytics and formulation development.

  7. Unravelling The Complexities Of ADC Development And Manufacturing 3/18/2025

    Whether you're in the early stages of development or scaling up for commercialization, understanding ADC manufacturing challenges is essential for bringing life-saving therapies to patients worldwide.

  8. Placing Drug Strategies On A Solid Foundation For Success 3/18/2025

    Explore how certain drivers are impacting traditional drug development strategies and relationships with outsourced drug development and manufacturing partners.

  9. How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs 3/17/2025

    Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.

  10. Your Most Pressing Tech Transfer Questions Answered 3/17/2025

    No two tech transfers are the same. To ensure success with yours, select a CDMO that will be astute in their onboarding analysis and commit to ongoing collaboration.